OncoSec Medical Inc (ONCS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Punit S. Dhillon
Employees:
37
5820 NANCY RIDGE DRIVE, SAN DIEGO, CA 92121
(858) 210-7333

OncoSec Medical, Inc. engages in designing, developing and commercializing medical products for the treatment of cancer. It engages in the discovery and development of novel immunotherapeutic products to improve treatment options for patients and physicians, which intends to treat oncology indications. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in San Diego, CA.

Data derived from most recent annual or quarterly report
Market Cap 67.399 Million Shares Outstanding39.185 Million Avg 30-day Volume 224.16 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 8.16 / 1.65 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from ONCS instead.

View recent insider trading info

Funds Holding ONCS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ONCS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DALESANDRO MARGARET

  • Director
20,000 2021-08-23 2

ZHAO YUHANG

  • Director
12,000 2021-08-20 2

DELAVERSANO ROBERT J VP, FINANCE

  • Officer
24,568 2021-08-01 4

DEMESA JAMES M

  • Director
25,000 2021-06-28 1

WARD ROBERT

  • Director
25,000 2021-06-28 1

LEUTHNER BRIAN A INTERIM CEO

  • Officer
211,387 2021-06-28 3

KIM JOON

  • Director
25,000 2021-06-28 1

SMITH KEVIN RAYMOND MERRILL

  • Director
25,000 2021-06-28 1

ZHOU CHAO

  • Director
  • 10% Owner
25,000 2021-06-28 1

LYERLY HERBERT KIM

  • Director
25,000 2021-06-28 1

O'CONNOR DANIEL J. CEO AND PRESIDENT

  • Officer
  • Director
96,097 2021-04-30 3

CHINA GRAND PHARMACEUTICAL & HEALTHCARE HOLDINGS LTD

GRAND DECADE DEVELOPMENTS LTD

SIRTEX MEDICAL US HOLDINGS, INC.

  • 10% Owner
  • SEE REMARKSSEE REMARKS
20,157,643 2021-04-16 1

ALPHA HOLDINGS, INC.

  • Director
1,718,251 2021-02-18 5

FOERTER KELLIE MALLOY CHIEF OPERATING OFFICER

  • Officer
0 2020-08-24 0

DHILLON AVTAR S

  • Director
No longer subject to file 2020-04-17 0

CHINA GRAND PHARMACEUTICAL & HEALTHCARE HOLDINGS LTD

SIRTEX MEDICAL US HOLDINGS, INC.

  • 10% Owner
  • SEE REMARKSSEE REMARKS
12,000,000 2020-02-07 1

BONSTEIN SARA CFO/COO

  • Officer
41,389 2020-01-16 0

MAYES, GREGORY T.

  • Director
0 2019-01-02 0

DHILLON PUNIT

  • Director
0 2019-01-02 0

SLANSKY RICHARD B CHIEF FINANCIAL OFFICER

  • Officer
270,016 2018-06-15 0

JENKINS ANNALISA

  • Director
0 2017-09-05 0

MOHAN-PETERSON SHEELA CHIEF LEGAL&COMPLIANCE OFFICER

  • Officer
9,520 2017-07-31 0

MAIDA ANTHONY E III

  • Director
0 2017-03-29 0

GARGOSKY SHARRON E CHIEF CLINICAL & REG. OFFICER

  • Officer
0 2017-03-29 0

PIERCE ROBERT HAMILTON CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-03-04 0

LE MAI HOPE CHIEF MEDICAL OFFICER

  • Officer
0 2015-08-20 0

VALLEJO VERONICA CHIEF FINANCIAL OFFICER

  • Officer
0 2015-03-03 0

CROSS MICHAEL CHIEF OPERATING OFFICER

  • Officer
1,214,000 2011-03-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ONCOSEC MEDICAL INC ONCS 2021-10-26 18:45:03 UTC -6.0372 6.1072 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 18:15:03 UTC -6.0372 6.1072 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 17:45:03 UTC -6.0372 6.1072 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 17:15:03 UTC -6.0372 6.1072 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 16:45:04 UTC -6.0372 6.1072 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 16:15:03 UTC -6.0372 6.1072 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 15:45:03 UTC -6.0372 6.1072 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 15:15:03 UTC -6.0372 6.1072 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 14:45:03 UTC -5.5077 5.5777 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 14:15:05 UTC -5.5077 5.5777 850000
ONCOSEC MEDICAL INC ONCS 2021-10-26 13:45:03 UTC -5.5077 5.5777 900000
ONCOSEC MEDICAL INC ONCS 2021-10-26 13:15:03 UTC -5.5077 5.5777 900000
ONCOSEC MEDICAL INC ONCS 2021-10-26 12:45:03 UTC -5.5077 5.5777 900000
ONCOSEC MEDICAL INC ONCS 2021-10-25 22:15:03 UTC -5.5077 5.5777 900000
ONCOSEC MEDICAL INC ONCS 2021-10-25 21:45:03 UTC -5.6122 5.6822 900000
ONCOSEC MEDICAL INC ONCS 2021-10-25 21:15:03 UTC -5.6122 5.6822 900000
ONCOSEC MEDICAL INC ONCS 2021-10-25 20:45:03 UTC -5.8751 5.9451 900000
ONCOSEC MEDICAL INC ONCS 2021-10-25 20:15:03 UTC -5.8751 5.9451 900000
ONCOSEC MEDICAL INC ONCS 2021-10-25 19:45:04 UTC -5.8751 5.9451 900000
ONCOSEC MEDICAL INC ONCS 2021-10-25 19:15:03 UTC -5.8751 5.9451 900000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC OncoSec Medical Inc 0.64% 2019-05-31 UK
Squarepoint Ops LLC OncoSec Medical Inc 0.54% 2019-05-30 UK
Squarepoint Ops LLC OncoSec Medical Inc 1.98% 2019-08-15 UK

Elevate your investments